A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rezpegaldesleukin in the Treatment of Adult Patients with Moderate to Severe Atopic Dermatitis (REZOLVE-AD)

Project: Research

Project Details

StatusActive
Effective start/end date24/06/24 → 23/06/26

Keywords

  • Clinical Trials
  • 23-358-05

Clinical Trial Phase

  • Phase II